 |
 |
 |
|
|
|||
|
|
||||
|
||||
ONCOLOGY: Clinical Trial Of DCVax(R)-L In Ovarian CancerFrom: Hope Waltman (anonymous@obgyn.net)Sun, 28 Dec 2008 17:33:36 -0600 (CST)
Northwest Biotherapeutics Reports Encouraging Data On First Patients Who Have Completed Its Phase I/II Clinical Trial Of DCVax(R)-L In Ovarian Cancer DCVax(R)-L is a groundbreaking personalized vaccine that takes a patient's own immune cells and trains them in the laboratory to attack the biomarkers from that patient's own tumor cells. Metastatic ovarian cancer poses a particularly serious and urgent unmet medical need. In most patients, the disease is not discovered until is it already late stage, because ovarian cancer typically causes little or no symptoms until it is late stage. When this cancer has metastasized, as in the case of the no-option patients in NWBT's trial, the cancer usually progresses rapidly and aggressively. This trial is ongoing, and is treating "no option" patients who have already been treated with most or all major drugs currently available for recurrent, metastatic ovarian cancer (including carboplatin, paclitaxel, docetaxel, abraxane, gemcitabine and topotecan), and whose cancer has still continued to progress. http://www.medicalnewstoday.com/articles/134058.php Regards, Hope Waltman, WHF Moderator http://www.hopeforfibroids.org
|
|
Return to ![[ Women's Health Forum ]](http://www.obgyn.net/images_women/wh-forum.gif)
Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Dec 2 06:56:27 2009
Women's Insurance Checklist from Auto Insurance Quote
home | medical professionals | women | industry | forums | international